P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Main Authors: | Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2 |
Similar Items
-
Porche 915 1969-76 autobook/
by: 206830 Ball, Kenneth
Published: (1978) -
AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
by: Sikander Ailawadhi, et al.
Published: (2023-01-01) -
Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
by: Lee, HC, et al.
Published: (2024) -
9.15 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2001
by: Wurtman, Richard J., 1936-
Published: (2001) -
P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY
by: A. Oriol, et al.
Published: (2022-06-01)